GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » EBIT per Share

Transcenta Holding (HKSE:06628) EBIT per Share : HK$-0.92 (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Transcenta Holding EBIT per Share?

Transcenta Holding's EBIT per Share for the six months ended in Jun. 2024 was HK$-0.34. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.92.

During the past 3 years, the average EBIT per Share Growth Rate was -11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Transcenta Holding's EBIT per Share or its related term are showing as below:

HKSE:06628' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -11.3   Med: -10.7   Max: -10.1
Current: -11.3

During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Transcenta Holding was -10.10% per year. The lowest was -11.30% per year. And the median was -10.70% per year.

HKSE:06628's 3-Year EBIT Growth Rate is ranked worse than
68.01% of 1241 companies
in the Biotechnology industry
Industry Median: 2.9 vs HKSE:06628: -11.30

Transcenta Holding's EBIT for the six months ended in Jun. 2024 was HK$-136.34 Mil.

Transcenta Holding EBIT per Share Historical Data

The historical data trend for Transcenta Holding's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transcenta Holding EBIT per Share Chart

Transcenta Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
-1.04 -0.82 -11.34 -1.01 -1.20

Transcenta Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.52 -0.51 -0.62 -0.59 -0.34

Transcenta Holding EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Transcenta Holding's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-488.704/407.032
=-1.20

Transcenta Holding's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

EBIT per Share(Q: Jun. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-136.339/405.634
=-0.34

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transcenta Holding  (HKSE:06628) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Transcenta Holding EBIT per Share Related Terms

Thank you for viewing the detailed overview of Transcenta Holding's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Transcenta Holding Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transcenta Holding Ltd (HKSE:06628) » Definitions » EBIT per Share
Comparable Companies
HKSE:02197 HKSE:00690 HKSE:02257 HKSE:06996 HKSE:08158 HKSE:09939 HKSE:02185 HKSE:01228 HKSE:02126 HKSE:02898 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
B6-501, 218 Xinghu Street, Biobay, Suzhou, CHN, 215123
Website
https://www.transcenta.com
Transcenta Holding Ltd is a clinical-stage biopharmaceutical company with fully integrated capacities in discovery, research, development, and manufacturing. It is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Geographically the company operates in China (the PRC) and the USA.
Executives
Qian Xueming 2101 Beneficial owner
Shi Xiaohong 2501 Other
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Lav Gp Iii, L.p. 2201 Interest of corporation controlled by you
Lav Biosciences Fund Iii, L.p. 2101 Beneficial owner
Shi Yi 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited
Tls Beta Pte. Ltd.
Hsbc Trust Company (delaware), N.a. 2301 Trustee
Success Link International L.p. 2101 Beneficial owner
Temasek Holdings (private) Limited
Lav Vitality Limited 2101 Beneficial owner
Zhong Guo Guo You Qi Ye Jie Gou Tiao Zheng Ji Jin Gu Fen You Xian Gong Si 2501 Other

Transcenta Holding Headlines

No Headlines